AFMDQ (Affimed NV) Shiller PE Ratio: (As of Sep. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AFMDQ Affimed NV AFMDQ
16 GF Score
Price $0.00
View Full Analysis

What is Affimed NV Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Affimed NV  (OTCPK:AFMDQ) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Affimed NV Shiller PE Ratio Related Terms


Affimed NV Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Affimed NV's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Affimed NV Shiller PE Ratio Chart

Affimed NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Affimed NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

AFMDQ vs SYRS, BTAX, TRVN: Shiller PE Ratio Comparison

For the Biotechnology subindustry, Affimed NV's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Affimed NV Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Affimed NV's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Affimed NV's Shiller PE Ratio falls into.


AFMDQ
16GF Score
Affimed NV AFMDQ
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Affimed NV Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Affimed NV's E10 for the quarter that ended in Sep. 2024 is calculated as:

For example, Affimed NV's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-1.043/126.1978*126.1978
=-1.043

Current CPI (Sep. 2024) = 126.1978.

Affimed NV Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 -2.713 99.543 -3.439
201503 -0.649 99.717 -0.821
201506 -2.132 100.417 -2.679
201509 -2.694 100.417 -3.386
201512 -2.070 99.717 -2.620
201603 -2.784 100.017 -3.513
201606 -2.697 100.717 -3.379
201609 -3.479 101.017 -4.346
201612 -1.688 101.217 -2.105
201703 -2.032 101.417 -2.529
201706 -2.022 102.117 -2.499
201709 -2.145 102.717 -2.635
201712 -1.657 102.617 -2.038
201803 -1.850 102.917 -2.268
201806 -1.519 104.017 -1.843
201809 -2.217 104.718 -2.672
201812 1.706 104.217 2.066
201903 0.339 104.217 0.410
201906 -1.921 105.718 -2.293
201909 -1.872 106.018 -2.228
201912 -2.111 105.818 -2.518
202003 -1.215 105.718 -1.450
202006 -1.802 106.618 -2.133
202009 -0.824 105.818 -0.983
202012 -2.068 105.518 -2.473
202103 0.119 107.518 0.140
202106 -1.928 108.486 -2.243
202109 -1.647 109.435 -1.899
202112 -2.158 110.384 -2.467
202203 -1.542 113.968 -1.707
202206 -1.374 115.760 -1.498
202209 -1.089 118.818 -1.157
202212 -2.373 119.345 -2.509
202303 -2.291 122.402 -2.362
202306 -2.134 123.140 -2.187
202309 -1.740 124.195 -1.768
202312 -1.472 123.773 -1.501
202403 -1.380 125.038 -1.393
202406 -1.087 125.882 -1.090
202409 -1.043 126.198 -1.043

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Affimed NV Business Description

Address Gottlieb-Daimler-Strabe 2, Mannheim, BW, DEU, 68165
Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.
16GF Score

Get the complete analysis for AFMDQ

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price